Due to its connection to inflammation and its cell-surface location as a GPCR, various BLT1 ligands have been designed and tested in clinical trials38 for a range of inflammatory diseases including asthma, COPD, rheumatoid arthritis, inflammatory bowel disease, and cancer18,19. The gene discussed is LTB4R; the disease is rheumatoid arthritis.